Bromodeoxyuridine labeling index in glioblastoma multiforme: Relation to radiation response, age, and survival
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 34 (4) , 803-808
- https://doi.org/10.1016/0360-3016(95)02027-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markersCancer, 1994
- Prognostic Significance of Flow Cytometry Deoxyribonucleic Acid Analysis of Human AstrocytomasNeurosurgery, 1994
- Intratumoral heterogeneity of malignant gliomas measured in-vitroInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Comparison of three quantitation methods for PCNA immunostaining: Applicability and relation to survival in 83 astrocytic neoplasmsThe Journal of Pathology, 1993
- Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labelingInternational Journal of Cancer, 1993
- Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significanceZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Nucleolar Organizer Regions in Vascular and Neoplastic Cells of Human GliomasNeurosurgery, 1991
- Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumoursActa Neurochirurgica, 1991
- Correlation of histopathological features and proliferative potential of gliomasJournal of Neurosurgery, 1989
- Brain-tumor cell kinetics correlated with survivalJournal of Neurosurgery, 1986